Genedrive.
65 announcements.
65 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 22-11-2024 | GDR | Genedrive | Notice of Results |
| 11:06 | 21-11-2024 | GDR | Genedrive | NIHR and OLS Funding Package |
| 13:29 | 04-11-2024 | GDR | Genedrive | Scottish Health Technology Group publications |
| 15:22 | 21-10-2024 | GDR | Genedrive | Director Declaration |
| 10:39 | 15-08-2024 | GDR | Genedrive | Director/PDMR Shareholding |
| 07:00 | 12-08-2024 | GDR | Genedrive | First UK commercial sales of the CYP2C19-ID Kit |
| 07:00 | 06-08-2024 | GDR | Genedrive | Directorate Change |
| 07:00 | 31-07-2024 | GDR | Genedrive | NICE recommends CYP2C19-ID Kit in final guidance |
| 07:00 | 15-07-2024 | GDR | Genedrive | Breakthrough Device Designation from the U.S. FDA |
| 09:28 | 27-06-2024 | GDR | Genedrive | Short extension to NICE publication date |
| 07:00 | 25-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 11:12 | 24-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 11:11 | 24-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 11:13 | 24-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 16:41 | 17-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 15:22 | 13-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 12:54 | 11-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 11:00 | 07-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 15:45 | 05-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 11:39 | 05-06-2024 | GDR | Genedrive | Holding(s) in Company |
| 15:56 | 31-05-2024 | GDR | Genedrive | Block listing returns |
| 11:24 | 31-05-2024 | GDR | Genedrive | Result of General Meeting |
| 07:00 | 30-05-2024 | GDR | Genedrive | Result of Open Offer and REX Offer |
| 07:00 | 24-05-2024 | GDR | Genedrive | Initial orders of the Genedrive MT-RNR1 Products |
| 07:00 | 15-05-2024 | GDR | Genedrive | Amendment to Open Offer timetable |
| 07:00 | 14-05-2024 | GDR | Genedrive | Publication of Circular and Notice of GM |
| 07:00 | 10-05-2024 | GDR | Genedrive | Completion of placing |
| 16:48 | 09-05-2024 | GDR | Genedrive | Proposed Fundraise for a minimum of £6.0 million |
| 16:49 | 09-05-2024 | GDR | Genedrive | Proposed REX Retail Offer |
| 15:36 | 24-04-2024 | GDR | Genedrive | Clinical Trial Agreement |
| 17:00 | 03-04-2024 | GDR | Genedrive | Application for Listing & Total Voting Rights |
| 07:00 | 03-04-2024 | GDR | Genedrive | NICE recommends the Genedrive CYP2C19-ID Kit |
| 07:00 | 28-03-2024 | GDR | Genedrive | Half-year Report |
| 15:53 | 19-03-2024 | GDR | Genedrive | Application for Listing & Total Voting Rights |
| 12:30 | 15-03-2024 | GDR | Genedrive | Receipt of R&D tax credit |
| 07:00 | 19-02-2024 | GDR | Genedrive | NICE Early Value Assessment update |
| 14:03 | 06-02-2024 | GDR | Genedrive | Director/PDMR Shareholding |
| 15:35 | 02-02-2024 | GDR | Genedrive | Total Voting Rights |
| 16:14 | 19-01-2024 | GDR | Genedrive | Total Voting Rights |
| 15:21 | 15-01-2024 | GDR | Genedrive | Total Voting Rights |
| 07:00 | 10-01-2024 | GDR | Genedrive | Total Voting Rights |
| 07:00 | 02-01-2024 | GDR | Genedrive | Equity Prepayment Facility drawdown |
| 11:44 | 29-12-2023 | GDR | Genedrive | Result of AGM |
| 16:57 | 20-12-2023 | GDR | Genedrive | Total Voting Rights |
| 07:00 | 20-12-2023 | GDR | Genedrive | Initial overseas orders of MT-RNR1 ID kit |
| 07:00 | 07-12-2023 | GDR | Genedrive | Total Voting Rights |
| 07:00 | 06-12-2023 | GDR | Genedrive | Posting of annual report and notice of AGM |
| 07:00 | 06-12-2023 | GDR | Genedrive | Total Voting Rights |
| 13:13 | 04-12-2023 | GDR | Genedrive | MT-RNR1 ID kit adopted for routine use in Brighton |
| 17:29 | 30-11-2023 | GDR | Genedrive | Block listing Interim Review |
| 07:00 | 30-11-2023 | GDR | Genedrive | Final Results |
| 07:00 | 16-11-2023 | GDR | Genedrive | Notice of Results |
| 10:52 | 20-10-2023 | GDR | Genedrive | Total Voting Rights |
| 12:35 | 28-09-2023 | GDR | Genedrive | c£1.2m grant awarded |
| 14:39 | 21-09-2023 | GDR | Genedrive | Application for listing & total voting rights |
| 14:17 | 11-09-2023 | GDR | Genedrive | Board changes |
| 07:00 | 06-09-2023 | GDR | Genedrive | UKCA marking achieved for new CYP2C19 test |
| 16:00 | 04-08-2023 | GDR | Genedrive | Total Voting Rights |
| 09:11 | 05-07-2023 | GDR | Genedrive | Equity Prepayment Facility drawdown |
| 14:28 | 16-06-2023 | GDR | Genedrive | Holding(s) in Company |
| 07:00 | 16-06-2023 | GDR | Genedrive | Multi-partner grant awarded |
| 12:25 | 02-06-2023 | GDR | Genedrive | Equity Prepayment Facility drawdown |
| 07:00 | 31-05-2023 | GDR | Genedrive | Block Listing Returns |
| 07:00 | 19-05-2023 | GDR | Genedrive | NICE recommends CYP2C19 genotyping |
| 11:58 | 11-05-2023 | GDR | Genedrive | Result of General Meeting |